Meibomian gland dysfunction (MGD) may be misdiagnosed. While MGD is one of the most common chronic ocular conditions, diagnosing MGD isn’t as simple as it seems.
Not all situations can be handled within one office, so sometimes it is necessary to refer patients elsewhere. Despite the logic behind them, referrals often come bundled with liabilities that can give any OD a headache.
Stem cell technology may soon enter the mainstream as a treatment for ocular disease, says Leo Semes, OD, FAAO, at this year’s annual SECO 2017 conference.
Treatment of posterior segment disease is in the midst of a paradigm shift, says a panel of experts at this year's annual SECO 2017 conference in Atlanta.
The American healthcare system is failing eye care